| Patents for C07D 261 - Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings (11,459) |
|---|
| 09/19/2007 | CN100338073C Substituted phenylacetic acids |
| 09/18/2007 | US7271178 Heterocyclic inhibitors of MEK and methods of use thereof |
| 09/13/2007 | US20070213374 Malonamide Derivatives |
| 09/13/2007 | US20070213348 Chemical Compounds |
| 09/13/2007 | US20070213333 Suppress production of both prostaglandins and leukotrienes and have reduced side effects; treatment of various inflammatory diseases, autoimmune diseases, allergic diseases, pain and fibrosis; for example, methyl 3-[3-acetylamino-4-cyclopentyloxy-5-(naphthalen-2-yl)phenyl]propionate |
| 09/13/2007 | US20070213316 N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 09/13/2007 | US20070212709 Non-nucleosidic linker linking xanthene donor to 4,7-dichlororhodamine acceptor; |
| 09/12/2007 | EP1831145A1 Substituted oxyarenes |
| 09/12/2007 | CN101035774A Modulators of CRTH-2 receptor activity for the treatment of prostaglandin D2 mediated diseases |
| 09/11/2007 | US7268234 Reaction of 1,2-benzisoxazole-3-acetic acid in toluene with chlorosulfonic acid optionally mixed with an inert solvent in the presence of a particular Lewis base (ester or a nitrile) to produce 1,2-benzisoxazole-3-methanesulfonamide |
| 09/11/2007 | US7268140 (2S)-1-((4-chlorophenoxy)methyl)carbonyl-2-methyl-4-(4-fluorobenzyl)piperazine; inhibit the activity of the chemokines, MIP-1 alpha and RANTES |
| 09/11/2007 | US7268135 Biaryl sulfonamides and methods for using same |
| 09/11/2007 | US7268132 Thio substituted with a hetero multiring group; sleepiness, promotion of wakefulness, Parkinson's disease, cerebral ischemia, stroke, sleep apneas, eating disorders, stimulation of appetite and weight gain, attention deficit hyperactivity disorder |
| 09/11/2007 | CA2318368C Novel tricyclic compound |
| 09/05/2007 | EP1829868A1 Process for production of (4,5-dihydroisoxazol-3-yl)thio- carboxamidine salts |
| 09/05/2007 | EP1829858A2 Dibenzylamine compounds and pharmaceutical use thereof |
| 09/05/2007 | EP1828118A1 Parp inhibitors |
| 09/05/2007 | EP1492796B1 Substituted amino isoxazoline derivatives and their use as anti-depressants. |
| 09/05/2007 | CN101031540A 六氟异丙醇取代的醚衍生物 Hexafluoroisopropanol substituted ether derivatives of |
| 09/05/2007 | CN101031539A Substituted arylalkanoic acid derivatives and use thereof |
| 09/04/2007 | US7265220 Amino acid derivatives, method for production thereof and pharmaceutical compositions comprising said derivative |
| 09/04/2007 | US7265130 anti-obestic activity; Neuropeptide Y antagonist |
| 09/04/2007 | US7265093 administering a transglutaminase inhibitor, particularly a compound with a 3-halo-dihydroisoxazole moiety or an analog of isatin, to attenuate gluten toxicity |
| 08/30/2007 | WO2007097403A1 Remedy or preventive for digestive ulcer |
| 08/30/2007 | WO2007097279A1 Process for production of 3-[5-[4-(cyclopentyloxy)-2-hydroxybenzoyl]-2-[(3-oxo-2-substituted-2,3-dihydro-1,2-bezisoxazol-6-yl)methoxy]phenyl]propionate ester and intermediate for the process |
| 08/30/2007 | WO2007096647A2 Diaryl compounds as non-steroidal inhibitors of 17-beta hydroxysteroid dehydrogenase and/or steroid sulphatase for the treatment of oestrogen-related diseases such as hormone dependent breast cancer |
| 08/30/2007 | WO2007096576A1 Herbicidal isoxazoline compounds |
| 08/30/2007 | US20070203207 Heteroaromatic glucokinase activators |
| 08/30/2007 | US20070203205 treatment and/or prevention of adverse conditions of the central nervous system, including sleep disorders such as insomnia, psychotic disorders such as schizophrenia and psychiatric disorders such as anxiety; example (1S)-1-[2-({4-[(E)-2-(4-fluorophenyl)vinyl]phenyl}sulfonyl)phenyl]ethanol |
| 08/30/2007 | US20070202160 Solid-state form of celecoxib having enhanced bioavailability |
| 08/30/2007 | CA2817676A1 Process for production of 3-[5-[4-(cyclopentyloxy)-2-hydroxybenzoyl]-2-[(3-oxo-2-substituted-2,3-dihydro-1, 2-benzisoxazol-6-yl)methoxy]phenyl]propionate ester and intermediate for the process |
| 08/30/2007 | CA2643670A1 Diaryl compounds as non-steroidal inhibitors of 17-beta hydroxysteroid dehydrogenase and/or steroid sulphatase for the treatment of oestrogen-related diseases such as hormone dependent breast cancer |
| 08/30/2007 | CA2643272A1 Gent for treating or preventing digestive ulcer |
| 08/30/2007 | CA2643052A1 Process for production of 3-[5-[4-(cyclopentyloxy)-2-hydroxybenzoyl]-2-[(3-oxo-2-substituted-2,3-dihydro-1,2-benzisoxazol-6-yl)methoxy]phenyl]propionate ester and intermediate forthe process |
| 08/30/2007 | CA2640962A1 Herbicidal isoxazoline compounds |
| 08/29/2007 | EP1824821A2 Carbazole, carboline and indole derivatives useful in the inhibition of vegf production |
| 08/29/2007 | EP1824817A1 Arylsulfonylnaphthalene derivatives as 5ht2a antagonists |
| 08/29/2007 | EP1517899B1 Broadspectrum substituted benzisoxazole sulfonamide hiv protease inhibitors |
| 08/29/2007 | CN101027309A Enantiomers of selected fused pyrimidones and uses in the treatment and prevention of cancer |
| 08/29/2007 | CN101027056A Compounds for the treatment of dyslipidemia and other lipid disorders |
| 08/29/2007 | CN101024627A Nitrogen-containing aromatic derivatives |
| 08/28/2007 | US7262304 without isolation of intermediates in solid form; antiepileptic agent; 1,2-benzisoxazole-3-acetic acid as a starting agent |
| 08/28/2007 | US7262208 Hydroxypropyl amides for the treatment of Alzheimer's disease |
| 08/23/2007 | WO2007073518A9 Compounds and methods for thiol-containing compound efflux and cancer treatment |
| 08/23/2007 | WO2007015866A3 Inhibitors of p38 kinase and methods of treating inflammatory disorders |
| 08/23/2007 | US20070197610 Benzisoxazoles |
| 08/23/2007 | US20070197522 Dpp-iv inhibitors |
| 08/23/2007 | CA2641734A1 Acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndrome |
| 08/22/2007 | EP1819721A1 Microcin b17 analogs and methods for their preparation and use |
| 08/22/2007 | EP1819691A2 Biaryloxymethylarene carboxylic acids |
| 08/22/2007 | EP1756052A4 Improved method for preparing 3-hydroxy-4-hydroxymethyl-pyrrolidine compounds |
| 08/22/2007 | EP1379513B1 Prodrugs of cox-2 inhibitors |
| 08/22/2007 | CN101023086A Selected fused heterocyclics and uses thereof |
| 08/16/2007 | WO2007092190A2 Methods and compositions for modulating sphingosine-1-phosphate (s1p) receptor activity |
| 08/16/2007 | WO2007090752A1 Anthranilamide/2-amino-heteroarene carboxamide derivatives |
| 08/16/2007 | WO2007016208A3 1,2-benzisoxazole-3-methane-sulfonic acid ammonium salt |
| 08/16/2007 | WO2006084688A8 HIV protease inhibitors |
| 08/16/2007 | WO2003031404A3 Processes for the preparation of substituted isoxazoles and 2-isoxazolines |
| 08/16/2007 | CA2637771A1 Anthranilamide/2-amino-heteroarene carboxamide derivatives |
| 08/15/2007 | EP1818326A1 Nitrogen-containing heterocyclic compounds and pharmaceutical composition containing the compounds |
| 08/15/2007 | EP1818325A2 3,4-DI-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands |
| 08/15/2007 | EP1817292A2 Novel heterocycle derivatives useful as selective androgen receptor modulators (sarms) |
| 08/15/2007 | EP1437349B1 Substituted isoxazoles and the use thereof as antibiotics |
| 08/15/2007 | CN1331848C Tricyclic steroid hormone nuclear receptor modulators |
| 08/15/2007 | CN101018768A Improved method for preparing 3-hydroxy-4-hydroxymethyl-pyrrolidine compounds |
| 08/15/2007 | CN101018761A Methods and compositions for modulating sphingosine-1-phosphate(S1P) receptor activity |
| 08/15/2007 | CN101016296A Muscarinic agonists |
| 08/15/2007 | CN101016272A Synthetic method for 3-(2'-chloro-6'-fluorophenyl)-5-methyl-4-isooxazole formyl chloride |
| 08/15/2007 | CN101016271A High deliquescent metal hydrazone complex and synthetic method thereof |
| 08/15/2007 | CN101016270A Substituted piperazinphenylisoxazoline derivative and use thereof |
| 08/14/2007 | US7256206 1-[4-(3-Amino-4-hydroxy-3-hydroxymethyl-butyl)-phenyl]-ethanone-O-biphenyl-4-ylmethyl-oxime, used as modulators of lipid activated G-protein coupled receptors specific for sphingosine-1-phosphate; prevention of autoimmune diseases or as angiogenesis inhibitors |
| 08/09/2007 | WO2007087906A1 Fungicide n-cycloalkyl-benzyl-amide derivatives |
| 08/09/2007 | CA2632870A1 Fungicide n-cycloalkyl-benzyl-amide derivatives |
| 08/08/2007 | EP1815860A2 Phosphate transport inhibitors |
| 08/08/2007 | CN1330657C Novel piperidine and piperazine derivatives |
| 08/08/2007 | CN101014565A Diarylsulfones as 5-HT2a antagonists |
| 08/07/2007 | US7253286 Urea derivatives containing aromatic or heteroaromatic rings, useful as prophylactic or therapeutic agent for a disease for which angiogenesis inhibition is effective |
| 08/07/2007 | CA2190256C Process for preparing aromatic or heteroaromatic sulfonyl halides |
| 08/02/2007 | WO2007086076A2 An improved process for preparation of leflunomide |
| 08/02/2007 | WO2007085451A2 3,5-di (aryl or heteroaryl) isoxazoles and 1, 2, 4-oxadiazoles as s1p1 receptor agonists, immunosuppresssive and anti -inflammatory agents |
| 08/02/2007 | US20070179154 Coumarin derivatives, process for their production and use thereof |
| 08/02/2007 | US20070179153 Derivatives of heterocycles with 5 members, their preparation and their use as medicaments |
| 08/02/2007 | CA2637081A1 3,5-di (aryl or heteroaryl) isoxazoles and 1, 2, 4-oxadiazoles as s1p1 receptor agonists, immunosuppressive and anti -inflammatory agents |
| 08/01/2007 | EP1813606A1 Amide compound |
| 08/01/2007 | EP1812404A1 Indazoles, benzisoxazoles and benzisothiazoles and their use as estrogenic agents |
| 08/01/2007 | EP1537124B1 C-substituted tricyclic isoxazoline derivatives and their use as anti-depressants |
| 08/01/2007 | CN1329396C C-substituted tricyclic isoxazoline derivatives and their use as anti-depressants |
| 08/01/2007 | CN1329382C Novel arylsusfonamide compounds for treatment of obesity, type II diabetes and CNS-disorders |
| 07/31/2007 | USRE39754 Benzamide derivatives and pharmaceutical compositions containing same |
| 07/31/2007 | US7250432 Pharmaceutical compositions of diaryl-isoxazole derivatives for the prevention and treatment of cancers |
| 07/31/2007 | CA2175212C Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics |
| 07/31/2007 | CA2121253C Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics |
| 07/26/2007 | WO2007082910A1 Dicarbonylic compounds with antibacterial activity |
| 07/26/2007 | WO2007082840A1 Cyclohexyl sulfonamide derivatives having h3 receptor activity |
| 07/26/2007 | US20070173498 Melanin concentrating hormone antagonist |
| 07/26/2007 | CA2637449A1 Cyclohexyl sulfonamide derivatives having h3 receptor activity |
| 07/26/2007 | CA2637052A1 Dicarbonylic compounds with antibacterial activity |
| 07/25/2007 | EP1389190B1 Diamide invertebrate pest control agents containing a non-aromatic heterocyclic ring |
| 07/25/2007 | CN1328247C N-biphenylmethyl aminocycloalkanecarboxamide derivatives with a substiituent on the methyl useful as bradykinin antagonists |
| 07/25/2007 | CN101006065A Compounds and methods for inhibiting the interaction of BCL proteins with binding partners |